Eric Tetzlaff, PA-C

Request an Appointment Online - Click Here

New patients can request an appointment online or call
888-FOX-CHASE

Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111

Physicians Assistants

Physician Assistant
Medical Oncology

Meet other members of the
gastrointestinal cancer treatment team.
Meet other members of the
sarcoma cancer treatment team.

Certifications:

National Commission on Certification of Physician Assistants;
Pennsylvania State Board of Medicine

I chose to work at Fox Chase Cancer so that I could continue my career in oncology at an academic cancer center dedicated to providing quality care.

After graduating from the Duke University's Physician Assistant program in 2004, I began my career in oncology as a physician assistant at the M.D. Anderson Cancer Center in Texas.

At M.D. Anderson, I worked in the department of gastrointestinal medical oncology for four years specializing in the treatment of gastroesophageal and hepatobiliary cancers. I had the opportunity to publish several manuscripts in peer reviewed journals and present original research at national oncology conferences.

At Fox Chase, I am focusing on the clinical care of patients with sarcomas and gastrointestinal cancers.

Medical Education

Duke University, Durham, N.C., Master of Health Sciences, Physician Assistant Program, 2004

Professional Societies

American Academy of Physician Assistants;
American Society of Clinical Oncology;
International Society for Gastrointestinal Oncology;
Eugene A. Stead Physician Assistant Society, Duke University

Research Interests

Gastrointestinal Cancers Gastrointestinal Survivorship Care; Thromboembolism and Cancer

Publications

Research & Publications:

1. Tetzlaff ED, Davey M. Optimizing Adherence to Adjuvant Imatinib in Gastrointestinal Stromal Tumors. Journal of Advanced Practitioner in Oncology 2012; Submitted

2. Tetzlaff ED, Cen, P, Ajani JA. Emerging drugs in the treatment of advanced gastric cancer. Expert Opinion on Emerging Drugs 2008; 13:135-144.

3. Tetzlaff ED, Correa AM, Komaki R, Swisher SG, Ross W, Ajani JA. The significance of thromboembolic phenomena occurring before and during chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction. Diseases of the Esophagus 2008; 21:575-581.

4. Tetzlaff ED, Correa AM, Baker J, Ensor J, Ajani JA. Impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma. Cancer 2007; 109:1989-1995.

To make an appointment for treatment at Fox Chase, or if you have questions about cancer, call 1-888-FOX-CHASE (1-888-369-2427).

Fox Chase Cancer Center is a member of the National Comprehensive Cancer Network (NCCN), an alliance of 21 of the world's leading cancer centers

An NCI-designated
Comprehensive
Cancer Center

The Scientist names Fox Chase Cancer Center one of the Best Places to Work for PostDocs

Disclaimer: Temple University Health System (TUHS) neither provides nor controls the provision of health care. All health care is provided by its member organizations or independent health care providers affiliated with TUHS member organizations. Each TUHS member organization is owned and operated pursuant to its governing documents.